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A B S T R A C T
BACKGROUND AND PURPOSE
Evidence from animal models and examination of human epilepsy surgery specimens
indicates that inflammation plays an important role in epilepsy. Positron emission to-
mography (PET) using [C11]PK11195, a marker of activated microglia, provides a means
to visualize neuroinflammation in vivo in humans. We hypothesize that in patients with
active epilepsy, [C11]PK11195 PET (PK-PET) may be able to identify areas of focally
increased inflammation corresponding to the seizure onset zone.
METHODS
A young woman with intractable epilepsy underwent PK-PET as part of an approved re-
search study. PK-PET results were compared with results from other clinical studies.
RESULTS
PK-PET revealed an area of focally increased radiotracer uptake in the right frontal lobe
corresponding to this patient’s seizure focus as identified by ictal and interictal 18F-
fluorodeoxyglucose (FDG)-PET and EEG. Routine brain magnetic resonance imaging (MRI)
was initially considered normal, though high-resolution studies showed possible subtle
dysplasia of the right frontal lobe. The patient underwent a right frontal lobe resection,
and pathological evaluation showed focal cortical dysplasia with activated microglia.
CONCLUSIONS
PK-PET can identify neuroinflammation associated with subtle focal cortical dysplasia,
and may therefore have a clinical role in guiding epilepsy surgery for patients with
difficult-to-localize seizure foci.
Case Report
A 31-year-old woman had a 7-year history of complex
partial seizures consisting of behavioral arrest, rarely sec-
ondarily generalizing to a convulsion. She had no known
risk factors for epilepsy. BrainMRIwas initially considered nor-
mal, though subsequent high-resolution studies showed possible
subtle dysplasia of the right frontal lobe (Fig 1A). She was hos-
pitalized for persistent confusion after a seizure and was found
to be in complex partial status epilepticus. After treatment and
clinical recovery, frequent right frontal electrographic seizures
persisted (Fig 1B). An 18F-fluorodeoxyglucose (FDG) positron
emission tomography (FDG-PET) performed at this time, con-
sidered to be an ictal study, showed intense right frontal hy-
permetabolism (Fig 2A). A subsequent FDG-PET performed
during a seizure-free period after treatment with lorazepam
showed right frontal hypometabolism (Fig 2B). As part of an
approved research study, the patient provided informed con-
sent to undergo PET using [C11]PK11195, a radiotracer that
identifies brain inflammation by binding to the translocator
protein expressed by activated microglia.1 [C11]PK11195 PET
(PK-PET) has identified inflammation associated with multi-
ple sclerosis, Alzheimer’s Disease, and stroke,1 but has not yet
been applied to epilepsy, except for rare cases of epilepsy due to
known inflammatory causes such as vasculitis or encephalitis.2-4
Using a two-parameter linearized reference tissue model5 im-
plemented in PMOD (PMOD Technologies, Zurich, Switzer-
land), images of tracer uptake (relative to cerebellum) were
generated (Fig 2C). Focally increased [C11]PK11195 uptake
was apparent in the right frontal lobe in the same region iden-
tified as metabolically abnormal by ictal and interictal FDG
PET. Because the patient’s seizures were difficult to control
using medication, she underwent right frontal lobe resection.
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Fig 1. (A) A 3T MRI showing possible subtle right frontal lobe cortical dysplasia. (B) Electroencephalogram obtained at the time of the
patient’s first (ictal) FDG-PET study, showing a typical right frontal electrographic seizure (onset marked by arrow.) These seizures recurred
every 5-30 seconds throughout the 1-hour scanning session.
Surgery was guided by intraoperative electrocorticography,
which showed frequent epileptic activity in the right frontal
region corresponding to imaging abnormalities. Examination
of resected tissue revealed focal cortical dysplasia (FCD) with
prominent microglial activation (Fig 3). The patient is seizure
free 1 year after surgery.
Discussion
Inflammation is increasingly recognized to play a critical
role in the pathogenesis of epilepsy.6 This case illustrates
the ability of PK-PET to identify focal inflammation corre-
sponding to a patient’s seizure focus as identified by (rarely
obtainable) ictal FDG-PET, as well as interictal FDG-PET
and video-EEG. PK-PET localization of the seizure focus oc-
curred in the setting of very subtle and easily overlooked
MRI abnormality. Histopathological demonstration of acti-
vated microglia in tissue obtained at surgery confirms PK-
PET findings. This result broadens significantly the potential
use of PK-PET in epilepsy beyond patients with a known
systemic or CNS inflammatory process2-4 to include patients
Fig 2. (A) Ictal FDG-PET showing right frontal hypermetabolism. (B) Interictal FDG-PET showing right frontal hypometabolism. (C): PK11195-
PET overlaid on CT showing increased tracer uptake in right frontal lobe (as well as thalamus, a normal finding).
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Fig 3. (A) A 100× magnification H&E stain of right frontal lobe
tissue showing enlarged, bizarrely shaped, dysplastic neurons con-
sistent with focal cortical dysplasia. (B) A 100× magnification CD68
(KP1) stain showing excess microglia with activated morphology.
with focal epilepsy of unknown etiology, or epilepsy due to
FCD.
FCD is considered the most common etiology of medically
intractable epilepsy in children, and the second most common
etiology in adults.7 It is a common pathological diagnosis in pa-
tients with normal brain MRIs who undergo epilepsy surgery,
indicating that it is often not visible in routine neuroimaging
studies.8 Neuropathologically, FCD is a class of disorders in-
volving abnormal neuronal morphology (eg, balloon cells), or-
ganization (eg, disrupted lamination), and/or location (eg, ec-
topic neurons within white matter).9 Prior studies of FCD surgi-
cal specimens have demonstrated that neuronal abnormalities
are accompanied by neuroinflammation including activatedmi-
croglia, with the extent of microglial activation correlating with
seizure frequency.10 It is not knownwhether activatedmicroglia
are an intrinsic aspect of FCD, or a reactive phenomenon re-
flecting the near-constant epileptic activity typically associated
with FCD lesions.9 In either scenario, results from this case
support the utility of PK-PET in identifying subtle FCD.
In conclusion, this case demonstrates that PK-PET, by identi-
fying localized inflammation, can aid detection of subtle epilep-
togenic abnormalities such as FCD in the context of clinical
evaluations for epilepsy surgery. PK11195-PET could also be
used to inform development of novel anti-inflammatory strate-
gies to combat refractory epilepsy.
Study Funding: This study is supported by CURE and NINDS
5K23NS057579.
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